A good time to buy call options? That would be today, or yesterday, or anytime last week. I think a little AACR/ASCO buzz leading into earnings call will set trajectory upward from now to end of April. Target: $25-26 pre-ASCO. Anything goes post-ASCO. We will see ALL data at ASCO including several EGFR patient responses.